Fineline Cube

Follow:
14486 Articles
Hengrui's Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials
CompanyDrug

Hengrui’s Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise
CompanyDrug

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise

Innovent's Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor
CompanyDrug

Innovent’s Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation
CompanyDeals

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation

Boan Biotech's Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases
CompanyDrug

Boan Biotech’s Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases

Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront
CompanyDeals

Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront

Novo Nordisk's Semaglutide 7.2 mg sNDA Submitted for Weight Management
CompanyDrug

Novo Nordisk’s Semaglutide 7.2 mg sNDA Submitted for Weight Management

CSPC's JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management
CompanyDrug

CSPC’s JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management

MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring
CompanyMedical Device

MicroTech’s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring

Bio-heart's IberiRDN Wins New Zealand Nod as Only Dual-Approach Renal Denervation System
Medical Device

Bio-heart’s IberiRDN Wins New Zealand Nod as Only Dual-Approach Renal Denervation System

IASO-Bio's Fucaso Wins Hong-Kong Approval as First China CAR-T
CompanyDrug

IASO-Bio’s Fucaso Wins Hong-Kong Approval as First China CAR-T

BeOne's Sotoclax Wins FDA Priority Review for Mantle Cell Lymphoma
CompanyDrug

BeOne’s Sotoclax Wins FDA Priority Review for Mantle Cell Lymphoma